Testing the effectiveness of a new screening system for colorectal cancer screening: a community trial

Not Applicable

• Conditions: Colorectal cancer; Cancer

• Registration Number: ISRCTN18024315
• Lead Sponsor: niversity of Tabuk

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-19
• Last Update Posted: 10 December 2019
• Study Completion: 2022-09-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 440

Inclusion Criteria

1. Individuals of both genders at risk of colorectal cancer attending the selected hospitals (King Fahad Hospital and Ain Alhayat Medical Center in Tabuk) in addition to 18 public health centers
2. Aged 40 years and above
3. Saudi citizens and non-Saudis who are eligible to receive free public health services. Those who are not eligible to use the free public health service will be excluded
4. The participants will be interviewed at the start to collect baseline data about their risk of colorectal cancer

Exclusion Criteria

1. Those who are not eligible to use the free public health service in the Kingdom of Saudi Arabia
2. Patients who are already diagnosed or under follow-up with colorectal cancer care

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> The effectiveness of an Integrated Colo-rectal Cancer Screening System (ICRCSS) as measured by the percentage of individuals with average risk of CRC who:<br> 1. Underwent CRC screening<br> 2. Enrolled for follow-up after screening<br> 3. Screened positive for signs of a precancerous CRC condition<br> compared with individuals receiving routine care at 3 years after the start of the program.<br>

Secondary Outcome Measures

Name	Time	Method
<br> The effectiveness of an Integrated Colo-rectal Cancer Screening System (ICRCSS) as measured by the percentage of individuals with a high risk of CRC who:<br> 1. Underwent CRC screening<br> 2. Enrolled for follow-up after screening<br> 3. Screened positive for signs of a precancerous CRC condition<br> compared with individuals receiving routine care at 3 years after the start of the program.<br>